PARP Inhibitor Market
According to Intent Market Research, the PARP Inhibitor Market is expected to grow from USD 22.9 Billion in 2024-e at a CAGR of 9.0% to touch USD 38.4 Billion by 2030. The PARP Inhibitor Market is dominated by key players such as, AstraZeneca, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline, Eli Lilly and Company, and Roche Holding AG.